Clinical Coagulation, Malmö
271 – 280 of 660
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Genetic risk factors for inhibitors in haemophilia A
- Contribution to journal › Scientific review
-
Mark
Inhibitors in haemophilia: what have we learned from registries? A systematic review.
- Contribution to journal › Scientific review
-
Mark
Association between bleeding tendency and health-related quality of life in carriers of moderate and severe haemophilia.
- Contribution to journal › Article
-
Mark
FVIII inhibitors: pathogenesis and avoidance.
- Contribution to journal › Scientific review
-
Mark
Prevention and treatment of atherosclerosis in haemophilia - how to balance risk of bleeding with risk of ischaemic events
- Contribution to journal › Scientific review
-
Mark
Predictors of Successful Cardioversion with Vernakalant in Patients with Recent-Onset Atrial Fibrillation.
- Contribution to journal › Article
-
Mark
Introduction.
- Contribution to journal › Debate/Note/Editorial
-
Mark
Targeting Factor Replacement Therapy in Severe Hemophilia: Which Level Is Important?
- Contribution to journal › Article
-
Mark
Thrombin stimulates insulin secretion via protease-activated receptor-3.
- Contribution to journal › Article
-
Mark
Low pericyte coverage of endometrial microvessels in heavy menstrual bleeding correlates with the microvessel expression of VEGF-A.
- Contribution to journal › Article
